Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210031016 210021765 1.66 60.3 Curative (C) 2013-04-12 2013-05-19 Imatinib 400mg Y N 210033710 IMATINIB
210031017 210012233 1.84 26.3 Curative (C) 2014-06-04 2015-06-24 ALL UKALL60+ TRIAL Y N 210033717 UKALL60+
210031018 210031276 1.64 86.3 Palliative (P) 2017-09-16 2017-09-16 ALL UKALL60+ TRIAL N null 210033742 UKALL60+
210031019 210012239 1.6 59 Curative (C) 2015-09-10 2015-09-10 Imatinib 200mg N N 210033764 IMATINIB
210031020 210012245 1.77 70.2 Disease modification (D) 2014-01-13 2014-02-18 CHLORAMBUCIL + OBINUTUZUMAB N N 210033776 CHLORAMBUCIL + OBINUTUZUMAB
210031021 210012252 null 83.2 Palliative (P) 2015-05-12 2015-09-23 IMATINIB N N 210033792 IMATINIB
210031022 210012259 0 75.7 Curative (C) 2017-12-24 2018-02-22 METHOTREXATE N Y 210033811 METHOTREXATE
210031023 210012264 null 64.2 Curative (C) 2016-07-07 2016-09-06 IDELALISIB + RITUXIMAB N N 210033830 IDELALISIB + RITUXIMAB
210031024 210021784 1.68 99.7 Neo-adjuvant (N) 2016-04-22 2016-06-04 Triple / Double Intrathecal Therapy N N 210033831 TRIPLE INTRATHECAL
210031025 210021786 null 83.2 null 2015-07-23 2015-08-02 Imatinib 600mg Y N 210033839 IMATINIB
210031026 210012268 1.7 null Curative (C) 2018-04-13 2018-04-13 ALL UKALL60+ TRIAL N null 210033851 UKALL60+
210031027 210012272 1.78 114.1 Curative (C) null 2017-03-01 IMATINIB N null 210033859 IMATINIB
210031028 210031282 null 16.3 null 2015-11-16 2015-11-23 ALL UKALL60+ TRIAL null null 210033868 UKALL60+
210031029 210012277 -1 null null 2013-03-11 2013-06-18 ALL UKALL2003 TRIAL N N 210033900 UKALL 2003
210031030 210012280 1.78 86.9 Palliative (P) null 2015-08-19 Chlorambucil + Pred + Rituximab N N 210033901 CHLORAMBUCIL + RITUXIMAB
210031031 210012288 null null Curative (C) 2018-05-27 2018-05-27 HYDROCORTISONE IT + METHOTREXATE IT N N 210033953 METHOTREXATE
210031032 210012292 0 57.9 Palliative (P) 2019-03-22 2019-03-23 IMATINIB N N 210033985 IMATINIB
210031033 210021806 1.73 62 Adjuvant (A) 2018-05-23 2018-10-26 ALL UKALL2003 TRIAL 02 N 210034017 UKALL 2003
210031034 210021808 1.81 113.95 Disease modification (D) 2014-08-17 2014-08-29 Imatinib 600mg 02 N 210034019 IMATINIB
210031035 210012300 1.83 77.9 Disease modification (D) 2016-09-22 2016-10-26 CHLORAMBUCIL + RITUXIMAB N N 210034037 CHLORAMBUCIL + RITUXIMAB
210031036 210012310 1.71 72.4 Palliative (P) 2017-09-03 2017-09-03 Triple Intrathecal N N 210034070 TRIPLE INTRATHECAL
210031037 210012313 1.61 null Disease modification (D) 2015-06-24 2015-07-16 Triple / Double Intrathecal Therapy N N 210034090 TRIPLE INTRATHECAL
210031038 210027696 0 82 Disease modification (D) 2017-06-24 2017-12-24 Imatinib 600mg N N 210034098 IMATINIB
210031039 210012316 1.55 80 Disease modification (D) 2017-10-03 2017-12-05 Imatinib 400mg Y N 210034099 IMATINIB
210031040 210035077 1.67 81.4 Disease modification (D) 2017-03-04 2017-05-28 ALL UKALL60+ TRIAL 01 N 210034115 UKALL60+
210031041 210012324 1.59 44 Palliative (P) 2018-10-02 2018-10-03 Imatinib 400mg N N 210034118 IMATINIB
210031042 210027702 0 103.4 Curative (C) 2017-09-07 2018-04-06 IMATINIB N N 210034139 IMATINIB
210031043 210021826 1.66 99.8 Palliative (P) 2016-03-09 2016-03-09 METHOTREXATE N N 210034157 METHOTREXATE
210031044 210027704 1.79 58 Disease modification (D) 2019-07-29 2019-08-04 Imatinib 400mg 2 N 210034173 IMATINIB
210031045 210012336 null null Palliative (P) 2018-04-20 2018-04-20 ALL UKALL2003 TRIAL N N 210034178 UKALL 2003
210031046 210033549 1.5 66 Curative (C) 2013-10-25 2014-03-11 ALL UKALL60+ TRIAL 02 N 210034183 UKALL60+
210031047 210012339 1.74 12.7 Adjuvant (A) null 2018-09-11 IDELALISIB + RITUXIMAB Y N 210034234 IDELALISIB + RITUXIMAB
210031048 210012345 1.51 59.7 Curative (C) 2017-02-05 2017-04-06 CHLORAMBUCIL + OBINUTUZUMAB N N 210034306 CHLORAMBUCIL + OBINUTUZUMAB
210031049 210012350 null 72 Curative (C) 2017-07-20 2017-09-15 ALL UKALL2003 TRIAL N N 210034345 UKALL 2003
210031050 210012352 1.65 29.65 Curative (C) 2017-01-01 2017-01-01 Triple Intrathecal N null 210034354 TRIPLE INTRATHECAL
210031051 210012356 null null Palliative (P) 2016-02-09 2016-04-12 Imatinib 400mg 02 null 210034361 IMATINIB
210031052 210021842 1.7 76.4 Disease modification (D) 2014-05-04 2014-05-04 R Chlorambucil 2 N 210034369 CHLORAMBUCIL + RITUXIMAB
210031053 210021843 1.69 87.9 Curative (C) 2014-03-23 2014-03-23 ALL UKALL2003 TRIAL N N 210034384 UKALL 2003
210031054 210031301 1.6 65.75 Curative (C) 2013-07-09 2013-07-22 Triple / Double Intrathecal Therapy N null 210034437 TRIPLE INTRATHECAL
210031055 210012364 0 60 Curative (C) 2019-02-05 2019-03-15 ALL UKALL60+ TRIAL N N 210034490 UKALL60+
210031056 210012365 1.75 84 Disease modification (D) 2018-02-16 2018-05-19 IMATINIB 02 N 210034498 IMATINIB
210031057 210012370 1.73 73 Palliative (P) 2015-09-17 2015-11-06 IDELALISIB + RITUXIMAB 2 N 210034516 IDELALISIB + RITUXIMAB
210031058 210012376 1.77 85.9 Curative (C) 2018-09-21 2018-12-07 METHOTREXATE 02 N 210034526 METHOTREXATE
210031059 210012379 null 100.5 Disease modification (D) 2016-08-07 2016-08-07 ALL UKALL60+ TRIAL N N 210034566 UKALL60+
210031060 210012380 1.79 57.8 Palliative (P) 2016-06-02 2016-06-13 Triple Intrathecal N N 210034567 TRIPLE INTRATHECAL
210031061 210027725 1.74 55 Palliative (P) null 2017-09-07 ALL UKALL60+ TRIAL Y N 210034577 UKALL60+
210031062 210012385 1.79 116.5 Curative (C) 2014-10-31 2015-01-09 IDELALISIB + RITUXIMAB 02 N 210034596 IDELALISIB + RITUXIMAB
210031063 210012388 1.67 52.5 Disease modification (D) 2017-10-07 2017-10-07 Imatinib 600mg N N 210034609 IMATINIB
210031064 210033558 0 null Disease modification (D) 2013-10-14 2013-10-26 METHOTREXATE null null 210034652 METHOTREXATE
210031065 210037855 1.8 110 null 2017-07-04 2017-08-01 IDELALISIB + RITUXIMAB 02 N 210034666 IDELALISIB + RITUXIMAB